Interpace Biosciences, Inc. (IDXG)
USD 2.41
(-9.06%)
USD 2.41
(-9.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 40.21 Million | 31.83 Million | 41.31 Million | 32.39 Million | 24.07 Million | 21.89 Million |
| Cost of Revenue | 17.17 Million | 13.6 Million | 23.36 Million | 21.67 Million | 15.88 Million | 10.19 Million |
| Gross Profit | 23.04 Million | 18.23 Million | 17.94 Million | 10.72 Million | 8.19 Million | 11.69 Million |
| Operating Expenses | 20.23 Million | 22.07 Million | 29.68 Million | 37.28 Million | 32.12 Million | 22.29 Million |
| Selling, General and Administrative Expenses | 19.59 Million | 20.09 Million | 23.73 Million | 30.02 Million | 25.66 Million | 16.92 Million |
| Research and Development Expenses | 636 Thousand | 703 Thousand | 1.88 Million | 2.79 Million | 2.81 Million | 2.12 Million |
| Other Expenses | 868 Thousand | 1.27 Million | 4.06 Million | 4.46 Million | 3.65 Million | 263 Thousand |
| Cost and Expenses | 37.41 Million | 35.67 Million | 53.05 Million | 58.95 Million | 48.01 Million | 32.49 Million |
| Operating Income | 2.8 Million | -3.84 Million | -11.73 Million | -26.55 Million | -23.93 Million | -12.11 Million |
| Interest Expense | 1 Million | 1 Million | 920 Thousand | 549 Thousand | 440 Thousand | 331 Thousand |
| Income Tax Expense | 17 Thousand | 29 Thousand | -667 Thousand | 53 Thousand | -28 Thousand | 18 Thousand |
| Earnings before Tax | 1.12 Million | -5.83 Million | -15.41 Million | -26.14 Million | -26.66 Million | -12.18 Million |
| Net Income | 802 Thousand | -5.86 Million | -14.74 Million | -26.2 Million | -26.63 Million | -12.18 Million |
| Earnings Per Share Basic | 0.19 | -1.38 | -3.57 | -6.50 | -7.11 | -4.33 |
| Earnings Per Share Diluted | 0.18 | -1.38 | -3.57 | -6.50 | -7.11 | -4.33 |
| Weighted Average Shares Outstanding | 4.31 Million | 4.23 Million | 4.13 Million | 4.02 Million | 3.74 Million | 2.81 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.36 Million | 4.23 Million | 4.13 Million | 4.02 Million | 3.74 Million | 2.81 Million |
| Gross Margin | 0.57 | 0.57 | 0.43 | 0.33 | 0.34 | 0.53 |
| EBIT Margin | 0.10 | -0.12 | -0.20 | -0.67 | -0.83 | -0.32 |
| Profit Margin | 0.02 | -0.18 | -0.36 | -0.81 | -1.11 | -0.56 |
| EBITDA | 3.83 Million | -2.26 Million | -1.32 Million | -20.09 Million | -21.71 Million | -8.56 Million |
| Earnings Before Tax Margin | 0.07 | -0.12 | -0.28 | -0.82 | -0.99 | -0.55 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 12.29 Million | 12.04 Million | 10.27 Million | 40.21 Million | 10.28 Million | 9.07 Million |
| Cost of Revenue | 4.78 Million | 4.61 Million | 4.2 Million | 17.17 Million | 4.17 Million | 4.32 Million |
| Gross Profit | 7.5 Million | 7.43 Million | 6.07 Million | 23.04 Million | 6.1 Million | 4.75 Million |
| Operating Expenses | 5.6 Million | 5.17 Million | 5.19 Million | 20.23 Million | 4.79 Million | 4.77 Million |
| Selling, General and Administrative Expenses | 5.4 Million | 5.02 Million | 5.06 Million | - | 4.63 Million | 4.62 Million |
| Research and Development Expenses | 199 Thousand | 146 Thousand | 137 Thousand | - | 152 Thousand | 149 Thousand |
| Other Expenses | - | 71 Thousand | -82 Thousand | -667 Thousand | -259 Thousand | -252 Thousand |
| Cost and Expenses | 10.39 Million | 9.78 Million | 9.39 Million | 37.4 Million | 8.96 Million | 9.09 Million |
| Operating Income | 1.9 Million | 2.25 Million | 874 Thousand | 2.81 Million | 1.31 Million | -16 Thousand |
| Interest Expense | 145 Thousand | 188 Thousand | 216 Thousand | 1 Million | 234 Thousand | 256 Thousand |
| Income Tax Expense | 4000.00 | 4000.00 | 4000.00 | 17 Thousand | 6000.00 | 4000.00 |
| Earnings before Tax | 1.36 Million | 2.14 Million | 576 Thousand | 1.12 Million | 819 Thousand | -524 Thousand |
| Net Income | 1.28 Million | 2.06 Million | 468 Thousand | 802 Thousand | 890 Thousand | -614 Thousand |
| Earnings Per Share Basic | 0.29 | 0.47 | 0.11 | - | 0.21 | -0.14 |
| Earnings Per Share Diluted | 0.29 | 0.47 | 0.11 | - | 0.20 | -0.14 |
| Weighted Average Shares Outstanding | 4.39 Million | 4.37 Million | 4.37 Million | 4.31 Million | 4.33 Million | 4.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.42 Million | 4.4 Million | 4.38 Million | 4.36 Million | 4.34 Million | 4.31 Million |
| Gross Margin | 0.61 | 0.62 | 0.59 | 0.57 | 0.59 | 0.52 |
| EBIT Margin | 0.13 | 0.20 | 0.10 | - | 0.13 | 0.02 |
| Profit Margin | 0.10 | 0.17 | 0.05 | 0.02 | 0.09 | -0.07 |
| EBITDA | 1.59 Million | 2.44 Million | 1.03 Million | - | 1.36 Million | 224 Thousand |
| Earnings Before Tax Margin | 0.15 | 0.19 | 0.09 | 0.07 | 0.13 | -0.00 |
ANZGY
NPK
RGPMF
DATS
STOVEKRAFT
600673